Eom, G. D., Chu, K. B., Yoon, K. W., Mao, J., Heo,. Self-assembled influenza a neuraminidase virus-like particle vaccination confers protection against influenza B virus. Nanomedicine, 1–11
Background
Neuraminidase has gained increasing attention as a broadly reactive influenza vaccine antigen capable of mitigating the strain-specific limitations of hemagglutinin-based vaccines.
Methods
We generated an N1 virus-like particle (VLP) vaccine displaying NA from A/Guangdong-Maonan/SWL1536/2019 (H1N1) with M1 from A/California/4/2009 (H1N1), confirmed assembly by western blotting, hemagglutination assay, and transmission electron microscopy, and immunized BALB/c mice intranasally to measure antibody, cellular, and FcγRIV-mediated antibody-dependent cellular cytotoxicity responses.
Results
Intranasal immunization of BALB/c mice with N1-VLPs induced robust neuraminidase-specific IgG responses and markedly increased IgG- and IgA-secreting plasma cells in the lung. Vaccination also enhanced CD4+ and CD8+ T cell responses and expanded germinal center-like B cell populations. Functional antibody activity was demonstrated through FcγRIV-mediated antibody-dependent cellular cytotoxicity assays. Following challenge with B/Malaysia/2506/2004 (Victoria lineage), N1-VLP-immunized mice exhibited minimal weight loss, markedly reduced lung viral titers, and 100% survival, whereas na?ve controls experienced severe disease and high mortality.
Conclusion
These findings indicate that the N1 VLP vaccine induces measurable immune responses, confers protection against heterologous Victoria-lineage influenza B virus challenge in mice, and is well-tolerated.
Neuraminidase has gained increasing attention as a broadly reactive influenza vaccine antigen capable of mitigating the strain-specific limitations of hemagglutinin-based vaccines.
Methods
We generated an N1 virus-like particle (VLP) vaccine displaying NA from A/Guangdong-Maonan/SWL1536/2019 (H1N1) with M1 from A/California/4/2009 (H1N1), confirmed assembly by western blotting, hemagglutination assay, and transmission electron microscopy, and immunized BALB/c mice intranasally to measure antibody, cellular, and FcγRIV-mediated antibody-dependent cellular cytotoxicity responses.
Results
Intranasal immunization of BALB/c mice with N1-VLPs induced robust neuraminidase-specific IgG responses and markedly increased IgG- and IgA-secreting plasma cells in the lung. Vaccination also enhanced CD4+ and CD8+ T cell responses and expanded germinal center-like B cell populations. Functional antibody activity was demonstrated through FcγRIV-mediated antibody-dependent cellular cytotoxicity assays. Following challenge with B/Malaysia/2506/2004 (Victoria lineage), N1-VLP-immunized mice exhibited minimal weight loss, markedly reduced lung viral titers, and 100% survival, whereas na?ve controls experienced severe disease and high mortality.
Conclusion
These findings indicate that the N1 VLP vaccine induces measurable immune responses, confers protection against heterologous Victoria-lineage influenza B virus challenge in mice, and is well-tolerated.
See Also:
Latest articles in those days:
- Highly pathogenic avian influenza as a systemic risk - implications for control and preparedness 19 hours ago
- Multiple introductions and spread of novel reassortant highly pathogenic avian influenza A (H5N1) clade 2.3.4.4b viruses via wild birds, South Korea, 2024-2025 19 hours ago
- [preprint]The mammalian-adaptive PB2-E627K substitution preserves viral fitness of clade 2.3.4.4b H5N1 HPAIV in birds 1 days ago
- Mallard super-shedders of avian influenza exhibit distinct cloacal microbial abundance profiles 1 days ago
- A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge 1 days ago
[Go Top] [Close Window]
